Stocktoria
Genprex, Inc. GNPX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-03-29
Genprex, Inc. statistics & valuation
Market cap$5.4M
P / B0.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -159.7% | -511.9% | -289.2% | -94.6% | -48.2% |
| Return on equity | -203.8% | -1303.0% | -416.1% | -106.6% | -50.1% |
| Current ratio | 3.84 | 0.83 | 2.31 | 7.64 | 24.69 |
Source: SEC EDGAR filings · CIK 0001595248 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.